CME vs TW
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Feb 01, 2026
CME
64.8
AI Score
VS
CME Wins
TW
56.5
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CME | TW | Winner |
|---|---|---|---|
| Revenue | 4.87B | 1.53B | CME |
| Net Income | 2.89B | 487.80M | CME |
| Net Margin | 59.3% | 31.9% | CME |
| Operating Income | 3.21B | 614.33M | CME |
| ROE | 10.2% | 7.8% | CME |
| ROA | 1.5% | 6.1% | TW |
| Total Assets | 187.14B | 8.00B | CME |
| Cash | 2.45B | 1.91B | CME |
| Free Cash Flow | 3.09B | 790.56M | CME |
Frequently Asked Questions
Based on our detailed analysis, CME is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.